Latest Campaign Updates

The story of AllTrials

In May 2015, Trevor Butterworth, Director of Sense About Science USA, interviewed Ben Goldacre and Síle Lane to talk about the history of the AllTrials campaign.   

 

Almost half of all the clinical trials ever conducted have never been reported.
This is the story of the campaign to find them—and to fix medicine.
“I felt like I was […]

31st July 2015|

AllTrials US campaign officially launched

We are delighted to announce that today AllTrials USA has officially launched. Today 50 patient support groups, medical societies, universities and consumer groups are coming together to launch the AllTrials campaign in the US and to say:
“We are calling on everyone in our sector to join us in supporting the AllTrials campaign. Hundreds of thousands […]

29th July 2015|

Judgment in Richmond v HRA judicial review

Update: 30th July 2015

The Judge published his order today. He has made a declaration that the HRA has acted unlawfully because material on its website is “ambiguous and potentially misleading … in the specific respects and to the extent set out in the judgment.”

The Judge slammed Richmond for not being clear about what they were […]

28th July 2015|

Deworming story highlights benefits of sharing data

Ben Goldacre published a commentary in Buzzfeed yesterday that beautifully illustrates the true benefits of a transparent, open, networked approach to science.

In 2004, a hugely influential study was conducted in Kenya that showed children’s health, survival and school performance could be improved with a simple, cheap, annual deworming pill. The trial resulted in the deworming […]

24th July 2015|

Pharma company investors call for clinical trials transparency

Today investors representing more than €3.5 trillion in assets are asking the pharmaceutical companies they invest in to move towards transparency. The groups of 85 pension funds and asset managers support the aims of the AllTrials campaign and want the pharma companies to set out their plans to get clinical trials, past, present and future, […]

22nd July 2015|

Fixing flaws in science must be professionalised

The first evidence highlighting the serious problem of publication bias was published in 1986, accompanied by a simple solution – full registration of trials.1 Since then, many academics have published papers describing problems with evidence-based medicine, and yet, there has been very little effective action to fix these problems. Twenty eight years after the first […]

13th July 2015|

Public health groups sue FDA for access to trial data

Two public health groups have taken legal action to obtain access to clinical trial information about two new and expensive hepatitis C drugs, Sovaldi and Harvoni, manufactured by Gilead Sciences. A lawsuit was filed by Treatment Action Group (TAG), an AIDS research and policy think tank and member of AllTrials, and the Global Health Justice […]

30th June 2015|

Ongoing judicial review against the Health Research Authority

In March 2015 Richmond Pharmacology launched a judicial review against the Health Research Authority over its work to further clinical trial transparency.

28th July 2015
The Judgment in Richmond Pharmacology’s judicial review against the HRA has been published. The Judge Mr Justice Jay has said that the HRA has a clear legal right to check researchers’ compliance […]

26th June 2015|

Half of trials on high-risk cardiovascular devices remain unpublished

Only one in two clinical trials on high-risk medical devices for heart disease are published in a peer-reviewed journal, according to a new study published in The BMJ. These devices include implantable cardioverter-defibrillators, pacemakers, coronary stents, and artificial heart valves. Researchers searched an FDA database and found information about 177 clinical trials on 106 cardiovascular devices that received […]

24th June 2015|

Head-to-head clinical trials “almost always” back industry sponsor

A new study published in the Journal of Clinical Epidemiology has found that industry-sponsored clinical trials comparing different treatments “systematically yield favourable results for the sponsors.” Researchers looked at 319 trials with over 100 participants published in academic journals in 2011. Of the 182 trials funded by pharmaceutical companies 83% had positive results compared to […]

19th June 2015|